EUCTR2004-000786-35-IT进行中（未招募）不适用
A phase III, open-label, randomized, comparative study of the antiviral efficacy of ARV therapy with Lopinavir/Ritonavir (LPV/r - Kaletra) in combination with Tenofovir versus SOC (Kaletra in combination with 2 nucleoside RTIs) in naive HIV-1 positive patients
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- ABBOTT
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A phase III, randomized, comparative, open-label study of intravenous iron oligosaccharide (Monofer®) administered by infusions or repeated bolus injections in comparison with oral iron sulphate in inflammatory bowel disease subjects with iron deficiency anaemia - P-Monofer-IBD-01Inflammatory bowel disease subjects with iron deficiency anaemiaMedDRA version: 9.1 Level: LLT Classification code 10022972 Term: Iron Deficiency anaemiaMedDRA version: 9.1 Level: LLT Classification code 10021972 Term: Inflammatory bowel diseaseEUCTR2009-012544-16-GBPharmacosmos A/S350
进行中（未招募）
不适用
A phase III, randomized, comparative, open-label study of intravenous ironoligosaccharide (Monofer®) administered by infusions or repeated bolusinjections in comparison with oral iron sulphate in inflammatory boweldisease subjects with iron deficiency anaemia - Iron Oligosaccharide to patients with IBD and iron deficiency anaemiaEUCTR2009-012544-16-ATPharmacosmos A/S350
已完成
3 期
Research Study to demonstrate that intravenous iron oligosaccharide is non-inferior to oral iron sulphate in reducing iron deficiency anaemia secondary to inflammatory bowel disease (IBD), evaluated as the ability to increase haemoglobin (Hb).CTRI/2009/091/000983Pharmacosmos AS350
进行中（未招募）
不适用
A phase III, randomized, comparative, open-label study of intravenous iron oligosaccharide (Monofer®) administered by infusions or repeated bolus injections in comparison with oral iron sulphate in inflammatory bowel disease subjects with iron deficiency anaemia - Iron Ologisaccharide to patients with IBD and iron deficiency anaemiaInflammatory bowel disease subjects with iron deficiency anaemiaMedDRA version: 14.0Level: PTClassification code 10022972Term: Iron deficiency anaemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 14.0Level: PTClassification code 10021972Term: Inflammatory bowel diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2009-012544-16-HUPharmacosmos A/S350
进行中（未招募）
不适用
A phase III, randomized, comparative, open-label study of intravenous ironoligosaccharide (Monofer®) administered by infusions or repeated bolusinjections in comparison with oral iron sulphate in inflammatory boweldisease subjects with iron deficiency anaemia - Iron Oligosaccharide to patients with IBD and iron deficiency anaemiaEUCTR2009-012544-16-DKPharmacosmos A/S350